StockClub
HLTRFHLS Therapeutics Inc.$ --
HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLTRF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
15M USD
YoY -0.7%
Operating Income
0M USD
YoY +107.9%
Net Income
-1M USD
YoY +55.2%
EPS
-0.04$
YoY +54.4%

Revenue

$55.7M
FY2024 Q1$12.4M
$12.4M
Q1
FY2024 Q2$26.9M
$26.9M
Q2
FY2024 Q3$41M
$41M
Q3
FY2024 Q4$56.6M
$56.6M
Q4
FY2025 Q1$12.6M
$12.6M
Q1
FY2025 Q2$26.8M
$26.8M
Q2
FY2025 Q3$40.3M
$40.3M
Q3
FY2025 Q4$55.7M
$55.7M
Q4
Actual
$-826,722 (-1.5%)

Net Income

$-12.5M
FY2024 Q1$-6.1M
$-6.1M
Q1
FY2024 Q2$-11.8M
$-11.8M
Q2
FY2024 Q3$-16.6M
$-16.6M
Q3
FY2024 Q4$-19.6M
$-19.6M
Q4
FY2025 Q1$-4.4M
$-4.4M
Q1
FY2025 Q2$-7.2M
$-7.2M
Q2
FY2025 Q3$-11.1M
$-11.1M
Q3
FY2025 Q4$-12.5M
$-12.5M
Q4
Actual
+$7.2M (+36.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$56.1M
Est:$55.4M
FY2020BEAT
$56.1M
FY2021MISS
Actual:$60M
Est:$60.6M
FY2021MISS
$60M
FY2022MISS
Actual:$61.5M
Est:$62.9M
FY2022MISS
$61.5M
FY2023MISS
Actual:$63.1M
Est:$63.2M
FY2023MISS
$63.1M
FY2024MISS
Actual:$56.6M
Est:$56.8M
FY2024MISS
$56.6M
FY2025BEAT
Actual:$56.5M
Est:$55.1M
FY2025BEAT
$56.5M

Analyst Estimates